With changes in Medicaid eligibility looming, hospitals must plan now to keep patient care gaps at bay.
|Videos|July 9, 2014
Developing a Mid-Size Specialty Pharmacy
Author(s)Davy James, Associate Editor
Michael Nameth, RPh, MBA, chief executive officer of Aureus Health Services, discusses the growth of his company as a mid-size specialty pharmacy.
Advertisement
Michael Nameth, RPh, MBA, chief executive officer of Aureus Health Services, discusses the growth of his company as a mid-size specialty pharmacy.
This video was shot at the Armada Health Care 2014 Specialty Pharmacy Summit and Expo in Las Vegas, Nevada.
Advertisement
Related to this article
Apitegromab-mstn is cleared as an add-on to SMN2-targeted treatment for patients aged 2 and older, directly addressing muscle loss.
Once-daily oral deucrictibant extended-release significantly reduced hereditary angioedema attacks compared with placebo in the pivotal phase 3 CHAPTER-3 trial.
Advertisement
Advertisement
Trending on Pharmacy Times
1
How Pharmacists Overcome PCSK9 Inhibitor Access Barriers
2
Beyond Cost Avoidance: Advancing Unit-Level Pharmaceutical Economics in Health Systems
3
Pharmacists' Role as Ketone Monitoring Reaches Clinics
4
From Reactive to Proactive: AI's Role in Modern Pharmacy Safety
5